Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year?
SportOne-OffHealth & MedicineChess3mndManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingJa 70.1%
Voorspellers
12
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 10 uur geleden
Verouderd18 mrt 26, 22:53 UTC31 dec 26, 23:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026?
FutuurHow many patients will be treated under right-to-try in Montana within 2026?
FutuurWill Nectome have a preservation center by the end of the year?
Manifold MarketsWhat will be the life expectancy for American Cystic Fibrosis Patients in 2040?
Manifold MarketsWill some combination of the major cryonics companies accidentally thaw at least two patients before 2030?
Manifold MarketsNext Prime Minister of Romania?
PolymarketRegels
Brain preservation company Nectome is looking to start taking patients this year.
- Their chief of operations claims "90% confidence on [being able to preserve people by] December 2026". https://www.lesswrong.com/posts/E9xfgJHvs6M55kABD/less-dead?commentId=fkSjPfqybvNJffPs3
- Their founder said: "I think Alcor got it right when they designed their system for long-term care of people.
- They use a separate company to actually hold preserved people, so that if Alcor (the entity doing perservations) goes out of business, Alcor (the separate entity holding preserved people) continues its operations.
- Startups fail all the time because they take risks and are doing new things.
- But graveyards fail much less often, because they get initial endowments and have very predictable costs and few people to pay.
Open markten
Sports
KALSHISabalenka vs Noskova
- Aryna Sabalenka+6.0pt74.5%
- Linda Noskova-5.0pt25.5%
- Totaal volume
- € 12,2 mln.
- 24u volume
- € 11,2 mln.
POLYMARKETCounter-Strike: G2 vs Astralis (BO3) - FISSURE PLAYGROUND Group A
- 2 Winner+33.0pt100%
- O/U 2.5 Games+57.0pt100%
- 1 Rounds Handicap: Astralis (-3.5) vs G2 (+3.5)100%
+29 extra uitkomsten
POLYMARKETUEFA Champions League: 2027 Champion
- Barcelona18.1%
- Arsenal15.2%
- Paris Saint-Germain13.3%
+33 extra uitkomsten
- Totaal volume
- € 24 mln.
ROBINHOOD (ROTHERA)Aryna Sabalenka vs Linda Noskova Quarter Finals match
- Aryna Sabalenka72.6%
- Linda Noskova27.4%
- Totaal volume
- € 15,6K
- 24u volume
- € 1,9 mln.
KALSHIUS Open Men's Singles Winner
- Carlos Alcaraz57%
- Alexander Zverev+5.0pt26%
- Ben Shelton9%
+45 extra uitkomsten
- Totaal volume
- € 24,1 mln.
- 24u volume
- € 1,9 mln.
KALSHIClub Brugge vs Aston Villa
- Aston Villa+49.0pt87.1%
- Tie-17.0pt9.9%
- Club Brugge-31.0pt3%
- Totaal volume
- € 2,1 mln.
- BV Borussia 09 Dortmund vs. Villarreal CF
- US Open WTA: Aryna Sabalenka vs Linda Noskova
- Tiafoe vs Michelsen
- Genoa: Thiago Seyboth Wild vs Francesco Ferrari
- United Arab Emirates vs Bangladesh
- 2027 Pro Football Champion
- MLB: Chicago Cubs vs Milwaukee Brewers (Sep 7, 2026)
- MLB: New York Mets vs Miami Marlins (Sep 7, 2026)
- Amgen Irish Open Winner
- MLB: Arizona Diamondbacks vs Kansas City Royals (Sep 7, 2026)
- Real Madrid vs Inter
- US Open ATP: Frances Tiafoe vs Alex Michelsen
Veelgestelde vragen
- Wat zijn de huidige kansen voor Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year??
- Manifold Markets prijst Yes op 70% per 8 september 2026.
- Wanneer wordt Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year? afgewikkeld?
- Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year? wordt naar verwachting op 31 december 2026 afgewikkeld.
- Hoe wordt Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year? afgewikkeld?
- Manifold Markets wikkelt deze markt als volgt af: Brain preservation company Nectome is looking to start taking patients this year.